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Microembolization during coronary artery 
bypass grafting 
To the Editor: 
The article "Microemboli During Coronary Artery By- 
pass Grafting" by Clark and associates 1 discusses the 
genesis and effects on outcome of cerebral microemboli 
that occur during cardiopulmonary b pass. The authors 
used transcranial Doppler ultrasonography to monitor the 
incidence of cerebral microemboli and observed that the 
greatest number of microemboli occurred as a result of 
cardiac manipulation, removal of a partial crossclamp 
during construction of the proximal anastomoses, cannu- 
lation, and "unknown" causes, listed in descending order 
of incidence. In the published iscussion of this article, the 
method used for venting the left ventricle and the likeli- 
hood that the incidence of microemboli was related to the 
method of venting were questioned. The author replied 
that multiple methods were used, ranging from "none, to 
venting the pulmonary artery, to occasionally venting the 
left atrium. It was rare to vent the left side of the heart, 
however." 
My purpose is to draw attention to the "unknown" 
causes of microembolism and to suggest that the method 
of venting could affect he incidence of microembolism. In
1987, Robicsek and Duncan 2described conditions in the 
vented heart that facilitated retrograde air embolism 
through coronary arteriotomies made during coronary 
artery bypass operations. 13 supported their conclusions 
and have since studied my own population of patients 
having coronary artery bypass operations with reference 
to the presence or absence of air in the left ventricle 
before the ventricle was permitted to eject. 
All procedures were performed with intermittent ante- 
grade or antegrade-retrograde infusion of cold oxygen- 
ated crystalloid cardioplegic solution with venting of the 
left side of the heart hrough the aortic root. Proximal and 
distal anastomoses were performed with a single period of 
aortic crossclamping. After removal of the crossclamp, 
with the patient in a deep Trendelenburg position, the 
venous return to the heart was partially occluded to allow 
the heart to fill. The elevated apex was penetrated with a 
16-gauge needle and the hole was enlarged by a forceps. 
In a series of 328 patients, air was seen, and sometimes 
heard, to escape from the left ventricle in 33 or 10% of 
these patients. 
Clark and associates used a side-biting clamp for con- 
struction of their proximal anastomoses and a variety of 
venting methods, none of which was specified or studied 
as a separate ntity in their manuscript. If aortic root 
venting was one of the methods they used, air could have 
entered the left side of the heart through the open 
coronary arteriotomy (in one of our patients, air could be 
heard to be sucked into an arteriotomy). The infusion of 
cardioplegic solution directly into a graft may also intro- 
duce air into the left side of the heart by retrograde flow 
into the aorta. If the proximal anastomoses are performed 
with the aorta crossclamped, the interior of the aorta and 
the left ventricle as well (if the aortic valve is open) are 
exposed irectly to the atmosphere. 
It is clear that coronary artery bypass grafting is asso- 
ciated with a small but significant risk of transcoronary or
transaortic entry of air into the left side of the heart. 
Possibly the method of venting in some of the authors' 
patients could have contributed to the incidence of micro- 
embolism listed under "unknown" causes. I continue to 
urge that the left ventricle be regarded to contain air at all 
times in coronary artery bypass grafting and that it be 
evacuated irectly, if possible, before the heart is allowed 
to eject. 
Myles Edwin Lee, MD 
Centinela Hospital Medical Center 
Inglewood, CA 90301 
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Reply to the Editor: 
Dr. Lee is correct in stating that air microembolism can 
occur through open coronary arteriotomies and could 
have contributed to the "unknown" source group. Air 
accumulating in the left atrium or ventricle during the 
operation is not infrequent, as shown by transesophageal 
echocardiographic data and our published data demon- 
strating that lifting the heart to inspect the posterior 
anastomoses was associated with a significant incidence of 
abnormal velocity signals in the right middle cerebral 
artery. 
Venting of the ascending aorta with the vent attached to 
a cardiotomy return roller pump is the most common 
method now used at Allegheny General Hospital. No 
specific transcranial Doppler studies have been performed 
to determine which method of venting results in the least 
amount of postreperfusion microemboli and whether 
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there is concordance with postoperative clinical outcomes. 
Dr. Lee's venting method is that used since the dawn of 
cardiac surgery. It has withstood the test of time as being 
an excellent way to rid the left ventricle of significant 
amounts of air. Other techniques may be equally effica- 
cious. 
We thank Dr. Lee for bringing this source of microem- 
bolism into focus for a directed study. 
Richard E. Clark, MD 
Director, Cardiovascular and Pulmonary Research Center 
Allegheny-Singer Research Institute 
Pittsburgh, PA 15212 
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The scientific development of dynamic 
cardiomyoplasty 
To the Editor: 
The invited letter by Dr. Silverman 1 regarding the 
results of Dr. Moreira's group after 5 years of experience 
with dynamic ardiomyoplasty provided a useful analysis 
of the study and some general comments on cardiomyo- 
plasty. We cannot agree with his statement in the opening 
paragraph that the development of the technique did not 
conform to an idealized scientific progression. On the 
contrary, the evolution of cardiomyoplasty followed an 
unmistakable progression from observation to experimen- 
tal study to clinical application. As early as the 1960s, 
experimental studies attempting to use the mechanical 
power of skeletal muscle to assist he heart are detailed, 
but all faced the problem of muscle fatigue. In the 1970s, 
Salmons and Pette demonstrated, and published in Nature 
and The European Journal of Physiology (Pfluegers Ar- 
chives), that fatiguable fast-twitch muscle fibers could be 
transformed into fatigue-resistant slow-twitch fibers by 
slow-rate electrical stimulation. Further histochemical 
studies demonstrated that the metabolism of the fast- 
twitch muscles changed from glycolytic to oxidative, which 
is characteristic of slow-twitch fibers. This muscle plastic- 
ity resulted from the capacity of genes to code for various 
myosin isoforms. Research was initiated in our laboratory 
in 1980 to investigate the possibility that the same trans- 
formation could be obtained at heart frequency rates and 
that it could remain stable and efficient for many years. 
Using a goat animal model 2and newly developed latissi- 
mus dorsi muscle (LDM) pacing electrodes and an im- 
plantable Cardio-Myostimulator device, 3 we developed 
the surgical technique and the concept of progressive 
LDM training using an original protocol of progressive 
sequential stimulation. 4 It is with this background of 
5 years of animal experimentation in our unit, as well as 
several years of worldwide experimentation a d observa- 
tion, that the first clinical case was performed at Broussais 
Hospital in 1985. Despite having had the posterior wall of 
both ventricles replaced with an LDM flap, that patient 
remains well after 10 years and the flap retains fatigue- 
free contraction. 
Current clinical experience includes 80 cases from our 
institution and 500 cases worldwide. The international 
literature is extensive; three books and more than 100 
articles on basic research ave been published. There is a 
biennial International Meeting on Dynamic Cardiomyo- 
plasty and also an international multicentric study in 
conjunction with surgical centers from 15 countries. Their 
purpose is to evaluate results of both laboratory and 
clinical studies and to institute uniform protocols and 
postoperative schedules. Methods of evaluation continue 
to improve and studies involving left ventricular conduc- 
tance catheters and aortic modelflow methods now dem- 
onstrate improved cardiac function 6 to 24 months after 
cardiomyoplasty. 5 
Dr. Silverman urges participating groups to state that 
cardiomyoplasty may have only limited value. Jatene and 
Moreira 6have previously answered Dr. Silverman on this 
issue, stating that their intention was not to create enthu- 
siasm but to further present data and in the current article 
give reference to several studies on present limitations. In 
early publications Carpentier, 7 Chachques, 8 and their 
associates have repeatedly referred to the questionable 
efficiency and the future of the nascent echnique. Their 
more recent results are more encouraging--7 year's sur- 
vival of 52% and hospital mortality rate of 12% between 
1988 and 1995 (8/66 patients). Survival of patients with 
medical therapy alone in a well-matched population was 
significantly worse. 9
In summary, we do not agree with many of Dr. Silver- 
man's statements regarding cardiomyoplasty. The power 
of contraction of the LDM is impressive, generating four 
times the force of cardiac muscle. The fact that it can 
contract without fatigue for potentially more than 10 years 
is a powerful stimulus for investigation and trials because 
of the shortage of donors for transplantation. Bearing in 
mind that the mean survival of the first 100 heart trans- 
plantations was 29 days, the development of dynamic 
cardiomyoplasty has taken great strides ince its inception, 
both in the development of the biophysical science of 
adaptation of skeletal muscle and in the surgical tech- 
nique. The development of cardiomyoplasty has con- 
formed in the past to a rigorous scientific progression 
from observation to experimentation to patient applica- 
tion, 1° and it continues to conform. 
Juan C. Chachques, MD, PhD 
Alain F. Carpentier, MD, PhD 
Department of Cardiovascular Surgery 
Broussais Hospital 
96 rue Didot 
75014 Paris, France 
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